Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01539642Phase 3Completed
A Phase 3 trial of sufentanil in postoperative pain, sponsored by Talphera. Started Feb 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01539642.